title: Adenosine A2A Receptor Blockade Prevents Rotenone-Induced Motor Impairment in a Rat Model of Parkinsonism.
abstract: Pharmacological studies implicate the blockade of adenosine receptorsas an effective strategy for reducing Parkinson's disease (PD) symptoms. The objective of this study is to elucidate the possible protective effects of ZM241385 and 8-cyclopentyl-1, 3-dipropylxanthine, two selective A2A and A1 receptor antagonists, on a rotenone rat model of PD. Rats were split into four groups: vehicle control (1 ml/kg/48 h), rotenone (1.5 mg/kg/48 h, s.c.), ZM241385 (3.3 mg/kg/day, i.p) and 8-cyclopentyl-1, 3-dipropylxanthine (5 mg/kg/day, i.p). After that, animals were subjected to behavioral (stride length and grid walking) and biochemical (measuring concentration of dopamine levels using high performance liquid chromatography, HPLC). In the rotenone group, rats displayed a reduced motor activity and disturbed movement coordination in the behavioral tests and a decreased dopamine concentration as foundby HPLC. The effect of rotenone was partially prevented in the ZM241385 group, but not with 8-cyclopentyl-1,3-dipropylxanthine administration. The administration of ZM241385 improved motor function and movement coordination (partial increase of stride length and partial decrease in the number of foot slips) and an increase in dopamine concentration in the rotenone-injected rats. However, the 8-cyclopentyl-1,3-dipropylxanthine and rotenone groups were not significantly different. These results indicate that selective A2A receptor blockade by ZM241385, but not A1 receptor blockadeby 8-cyclopentyl-1,3-dipropylxanthine, may treat PD motor symptoms. This reinforces the potential use of A2A receptor antagonists as a treatment strategy for PD patients.
authors.affiliation: Faculty of Medicine, Department of Pharmacology, Suez Canal University Ismailia, Egypt.
authors.forename: Ahmed M
authors.initials: AM
authors.lastname: Fathalla
authors.affiliation: Faculty of Medicine, Department of Pharmacology, Suez Canal University Ismailia, Egypt.
authors.forename: Amira M
authors.initials: AM
authors.lastname: Soliman
authors.affiliation: Center for Aging and Associated Diseases, Zewail City of Science and Technology Giza, Egypt.
authors.forename: Mohamed H
authors.initials: MH
authors.lastname: Ali
authors.affiliation: Department of Veterans Affairs, New Jersey Health Care SystemEast Orange, NJ, USA; School of Social Sciences and Psychology and Marcs Institute for Brain and Behaviour, Western Sydney UniversitySydney, NSW, Australia.
authors.forename: Ahmed A
authors.initials: AA
authors.lastname: Moustafa
keywords: Parkinson’s disease; adenosine receptors; dopamine; grid walk; rotenone; stride length